EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications

Ioana Baldea iD, Cristian Iacoviță iD, Raul Andrei Gurgu, Alin Stefan Vizitiu, Vlad Râzniceanu iD, Daniela Rodica Mitrea

Nanomaterials · 04.10.2025 · 15 (19) · 1519

DOI: 10.3390/nano15191519 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 04.10.2025. Verfasst von Ioana Baldea und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Medicine and Pharmacy, Clinicilor 1, 400006 Cluj-Napoca, Romania. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 354 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron oxide nanoparticles (IONPs) have emerged as key materials in magnetic hyperthermia (MH), a minimally invasive cancer therapy capable of selectively inducing apoptosis, ferroptosis, and other cell death pathways while sparing surrounding healthy tissue. This review synthesizes advances in the design, functionalization, and biomedical application of magnetic nanoparticles (MNPs) for MH, highlighting strategies to optimize heating efficiency, biocompatibility, and tumor targeting. Key developments include tailoring particle size, shape, and composition; doping with metallic ions; engineering multicore nanostructures; and employing diverse surface coatings to improve colloidal stability, immune evasion, and multifunctionality. We discuss preclinical and clinical evidence for MH, its integration with chemotherapy, radiotherapy, and immunotherapy, and emerging theranostic applications enabling simultaneous imaging and therapy. Special attention is given to the role of MNPs in immunogenic cell death induction and metastasis prevention, as well as novel concepts for circulating tumor cell capture. Despite promising results in vitro and in vivo, clinical translation remains limited by insufficient tumor accumulation after systemic delivery, safety concerns, and a lack of standardized treatment protocols. Future progress will require interdisciplinary innovations in nanomaterial engineering, active targeting technologies, and real-time treatment monitoring to fully integrate MH into multimodal cancer therapy and improve patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

cancer therapyclinical translationimmunotherapyiron oxide nanoparticlesmagnetic hyperthermia

Autor:innen und Institutionen

  • Department of Physiology, University of Medicine and Pharmacy, Clinicilor 1, 400006 Cluj-Napoca, Romania.
  • Department of Pharmaceutical Physics-Biophysics, Faculty of Pharmacy, "Iuliu Hatieganu" University of Medicine and Pharmacy, 6 Pasteur St., 400349 Cluj-Napoca, Romania.

ORCID-Profile: Ioana Baldea, Cristian Iacoviță, Vlad Râzniceanu

Zitieren

APA

Baldea, I., Iacoviță, C., Gurgu, R. A., Vizitiu, A. S., Râzniceanu, V., & Mitrea, D. R. (2025). Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications. Nanomaterials, 15(19), 1519. https://doi.org/10.3390/nano15191519

Vancouver

Baldea I, Iacoviță C, Gurgu RA, Vizitiu AS, Râzniceanu V, Mitrea DR. Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications. Nanomaterials. 2025;15(19):1519. doi:10.3390/nano15191519

BibTeX
@article{Baldea2025,
  author = {Baldea, Ioana and Iacoviță, Cristian and Gurgu, Raul Andrei and Vizitiu, Alin Stefan and Râzniceanu, Vlad and Mitrea, Daniela Rodica},
  title = {Magnetic Hyperthermia with Iron Oxide Nanoparticles: From Toxicity Challenges to Cancer Applications},
  journal = {Nanomaterials},
  year = {2025},
  volume = {15},
  number = {19},
  pages = {1519},
  doi = {10.3390/nano15191519}
}
Kostenlos starten →